Author: pr web

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Axsome Therapeutics, Inc. (NASDAQ: AXSM) between December 30, 2019 and April 22, 2022, inclusive (the “Class Period”), of the important July 12, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Axsome securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Axsome class action, go to https://rosenlegal.com/submit-form/?case_id=2221 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Axsome’s chemistry, manufacturing, and control (“CMC”) practices were deficient with respect to AXS-07 and its manufacturing process; (2) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application (“NDA”) on its initially represented timeline; (3) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (4) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (5) as a result of all the foregoing, Axsome had overstated AXS-07’s regulatory and commercial prospects; and (6) as a result, Axsome’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Axsome class action, go to https://rosenlegal.com/submit-form/?case_id=2221 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enservco Corporation (NYSE American: ENSV) between May 13, 2021 and April 18, 2022, both dates inclusive (the “Class Period”), of the important July 19, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Enservco securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enservco class action, go to https://rosenlegal.com/submit-form/?case_id=6371 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Enservco had defective disclosure controls and procedures and internal control over financial reporting; (2) as a result, there were errors in Enservco’s financial statements relating to, inter alia, its transactions with Cross River Partners and accounting for Employee Retention Credits (“ERCs”); (3) accordingly, Enservco would need to restate certain of its financial statements and delay the filing of its 2021 annual report with the U.S. Securities and Exchange Commission (“SEC”); (4) Enservco downplayed the true scope and severity of its financial reporting issues; (5) accordingly, Enservco could not file its delayed 2021 annual report with the SEC within its initially represented timeline; and (6) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Enservco class action, go to https://rosenlegal.com/submit-form/?case_id=6371 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CareDx, Inc. (NASDAQ: CDNA) between February 24, 2021 and May 5, 2022, both dates inclusive (the “Class Period”), of the important July 22, 2022 lead plaintiff deadline.

SO WHAT: If you purchased CareDx securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the CareDx class action, go to https://rosenlegal.com/submit-form/?case_id=2700 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the RemoTraC service; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company’s testing services revenue reported throughout the Class Period artificially inflated; and (4) as a result, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the CareDx class action, go to https://rosenlegal.com/submit-form/?case_id=2700 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

Celebrate World String Change Day!

The world’s leading string company holds their inaugural string-themed holiday on June 6th

FARMINGDALE, N.Y., June 01, 2022 (GLOBE NEWSWIRE) — D’Addario, the world’s premier guitar string maker, is proud to announce the inaugural celebration of #WorldStringChangeDay on Monday, June 6, 2022.

As the world leader in guitar string innovation and quality, D’Addario is inviting musicians around the globe to celebrate the ritual and reward of caring for their instrument with a fresh set of strings.

“There’s nothing better than the feel and tone of fresh strings,” says acclaimed Brazilian Guitarist and Technician Lari Basilio. “It makes the playability smoother, the tone more vibrant, and inspires you again!”

Players on social media will be encouraged to show off how their instrument looks, plays, and sounds with fresh strings and dive into their own preferences and string-changing techniques.

Throughout the week leading up to #WorldStringChangeDay, Guitarists, Bassists, Ukulele, and Mandolin players across D’Addario’s worldwide artist roster, like Herman Li, Evan Taucher, Lari Basilio, JB Brubaker, Casper Esman, Mark Tremonti, and more will be sharing content around the importance of changing strings and maintaining your instrument.

“D’Addario strings have always been my go-to,” says Grammy-Nominated guitarist Michael Kiwanuka. “There’s just something about them that makes my guitar sound and feel the way it should. They’re the first step to achieving a great tone. With a fresh set of strings, I’m always inspired to pick up my guitar and play.”

As part of the new holiday, D’Addario will be hosting a giveaway via social media where players can post a story of them changing their strings for a chance to win a set of strings of their choice.

Musicians are encouraged to post on their social media pages using #WorldStringChangeDay to be a part of the conversation and have a chance to have their posts shared by D’Addario & Co.

D’Addario’s history of manufacturing guitar strings dates back to the 1600s in Salle, Italy. As part of their commitment to vertical integration, D’Addario manufactures more than 700,000 strings a day in Farmingdale, New York, made possible by their own in-house wire mill.

To learn more about how you can get involved, please visit: https://ddar.io/WSCD.PR

D’Addario & Company, Inc.

D’Addario is the world’s largest manufacturer of musical instrument accessories, marketed under several product brands: D’Addario Fretted, D’Addario Orchestral, D’Addario Woodwinds, Promark Drumsticks, Evans Drumheads, and Puresound Snare Wires. A family-owned and operated business with roots dating back to the 17th century, D’Addario now has over 1,100 employees worldwide, and manufactures 95% of its products in the U.S. while utilizing Toyota’s Lean manufacturing principles. D’Addario musical accessories are distributed in 120 countries, serve more than 3,300 U.S. retailers, all major e-commerce sites, and are the preferred choice of musicians worldwide such as, Keith Urban, Zac Brown, Brandi Carlile, Dave Matthews, Gary Clark Jr., Chris Thile, Ry Cooder, Joe Satriani, Julia Fischer, Anderson .Paak, Kacey Musgraves and more.

The D’Addario Foundation believes in the power of music to unlock creativity, boost self-confidence, and enhance academics. D’Addario also reinforces its role as a social and environmental leader with initiatives such as Playback and PlayPlantPreserve.

Media Contact – D’Addario & Co, Inc.
Natalie Morrison (natalie.morrison@daddario.com)
https://www.daddario.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/94e60972-3b85-46fd-aa13-11bf42c8927d

بیجنگ، 31 مئی 2022 /پی آر نیوز وائر/ — گلوبل ٹائمز آن لائن سے جاری رکھی خبر30 مئی 2022 کو جنوبی چین کے گوانگ ڈونگ صوبے شینزن میں سائیکل سواری کی ایک سرگرمی کا انعقاد کیا گیا جس کا مقصد “سائنس اور ٹیکنالوجی کے ساتھ سبز مستقبل کو روشن کرنا” تھا۔

اس سرگرمی میں لگ بھگ 30 جین-زرس جن میں چین، روس اور وینزویلا کے چار پُراثرسوشل میڈیا افراد، شنگھائی تعاون تنظیم (ایس سی او) یوتھ ٹیکنالوجی اینڈ انوویشن فورم کے شرکاء اور شینزن میں زندگی کے ہر شعبے کے نوجوان نمائندوں نے شرکت کی۔

انہوں نے مل کر چین کی ریفارم اور اوپننگ – اپ ڈرائیو  کے اہم مقامات اور دنیا کی سب سے قیمتی انٹرنیٹ فرموں میں سے ایک ٹینسینٹ کے ہیڈ کوارٹر کا دورہ کیا۔

انہوں نے لیان ہواشان پارک سے آغاز کیا اور شیکو ٹائم اسکوائر، ٹینسینٹ سی فرنٹ ٹاورز اور شینزن بے پارک کے ذریعے او سی ٹی اوہ بے پر فیرس وہیل پر سوار ہوئے۔

کم کاربن اور گرین ٹور کے دوران چینی اور غیر ملکی جین- زرز دونوں نے شینزن کی ریفارم اور اوپننگ – اپ کی تاریخ کو جانا اور نوخیز شہر کی تکنیکی ترقی اور اختراعی زندگی کا تجربہ کیا۔

سڑک پر آنے کے بعد جین-زرس نے سب سے پہلے ٹینسینٹ سی فرنٹ ٹاورز کا دورہ کیا جو انٹرنیٹ آف تھنگز (آئی او ٹی) اور مصنوعی ذہانت (اے آئی) جیسی نئی ٹیکنالوجیز کے لیے آزمائشی میدان ہے اور پھر وہ شیکو ٹائم اسکوائر سے گزرے جہاں انہوں نے شیکو انڈسٹریل زون کے سامنے ایک دیو قامت پوسٹر دیکھا جس پر “وقت دولت ہے، کارکردگی زندگی ہے” کا نعرہ درج تھا۔

جولائی 1979 میں شیکو انڈسٹریل زون نے شینزن میں تعمیر شروع کی جس نے چین کی ریفارم اور اوپننگ اپ کا “پہلا شاٹ” فائر کیا۔

پرمسرت ماحول میں جین-زرس نے شینزن بے پارک کا دورہ کیا جہاں انہوں نے ساحلی پٹی پر سائیکل چلانا شروع کر دی۔ اخر کار، وہ منزل پر پہنچے – او سی ٹی اوہ بے میں فیرس وہیل، جہاں انہوں نے ایک جدید شہر کے طور پر شینزن کی دلکشی، جدت طرازی اور خوشحالی کا تجربہ کیا۔

یہ سرگرمی ایس سی او یوتھ ٹیکنالوجی اینڈ انوویشن فورم کے لئے وارم اپ تھی، جو 31 مئی سے 2 جون کے درمیان شینزن میں منعقد ہوگی۔ فورم کا مقصد اختراعی تعاون، اختراعی تعلیم، ٹیلنٹ ٹریننگ، زرعی ترقی، دیہی غربت میں کمی، بین الاقوامی صحت تعاون، انفارمیشن انفراسٹرکچر کی تعمیر اور پائیدار ترقی میں دنیا بھر کے نوجوانوں کے درمیان دوستانہ تبادلے کو گہرا کرنا ہے۔

سائیکل سواری کی سرگرمی کو سوشل میڈیا پر لائیو اسٹریم کیا گیا اور متعدد چینی اور بیرون ملک پلیٹ فارموں پر زبردست توجہ دی گئی۔

Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen’s dihydro resveratrol is made by bioconversion from p-coumaric acid (pCA), a natural preservative Conagen produced by precision fermentation.

The same proprietary bioconversion technology used to make dihydro resveratrol can be used to make resveratrol and other polyphenol class molecules. Both compounds are natural metabolites of plants, such as berries and grapes, and are commonly found in red wine.

Because resveratrol and dihydro resveratrol exist in only very small quantities in plants, cultivation, extraction, and purification are very inefficient, using more land, water, and energy. Instead, Conagen starts with pCA made using fermentation of microorganisms. Bioconversion of pCA allows Conagen to use a much smaller footprint to make dihydro resveratrol and related compounds.

“The development of dihydro resveratrol demonstrates Conagen’s strong capability to manufacture and deliver innovative and versatile compounds for multiple large-scale applications,” said Casey Lippmeier, vice president of innovation. “Our proprietary bioconversion and precision fermentation capabilities enable the production of sustainable high-quality polyphenols for use in novel products which drive the growth of new markets.”

Resveratrol molecules in the category of polyphenols possess rich antioxidant properties. Its anti-inflammatory and antioxidant activity are linked to protective effects against heart disease, diabetes, cancer, and cognitive decline. Conagen has announced several polyphenol products over the past few years, such as Taxifolin BC-DHQ® (dihydroquercetin), kaempferol, Rosaval^™  rosmarinic acid, and hydroxytyrosol, establishing a strong leadership in the development of polyphenol compounds.

In addition to their importance in human health applications for improving the quality of life, dihydro resveratrol and resveratrol are also important industrial intermediates. They offer valuable use in many industrial applications, such as plastic additives, paints, resins, polymers, and high-temperature-resistant biomaterials.

Conagen is working with multiple industrial partners to develop novel applications of dihydro resveratrol, resveratrol, and related compounds.

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing service capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

Attachment

• Conagen develops new compound dihydro resveratrol

Ana Arakelian, Head of Public Relations and Communications
Conagen
+1.781.271.1588
ana.arakelian@conagen.com